Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

5.6%

46 terminated/withdrawn out of 826 trials

Success Rate

86.5%

+0.0% vs industry average

Late-Stage Pipeline

17%

141 trials in Phase 3/4

Results Transparency

6%

18 of 296 completed trials have results

Key Signals

191 recruiting18 with results38 terminated8 withdrawn

Enrollment Performance

Analytics

N/A
287(54.2%)
Phase 4
79(14.9%)
Phase 2
65(12.3%)
Phase 3
62(11.7%)
Phase 1
35(6.6%)
Early Phase 1
2(0.4%)
530Total
N/A(287)
Phase 4(79)
Phase 2(65)
Phase 3(62)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (826)

Showing 20 of 826 trials
NCT07727603Enrolling By Invitation

Global AI Governance: Maturity and Implementation in Leading Hospitals for Responsible AI in Healthcare

Role: lead

NCT05694065Active Not Recruiting

Functional ComprEhensive AssessmenT by IVUS Reconstruction in Patients With Suspected IschEmic Heart Disease (FEATURE)

Role: collaborator

NCT06267430Not ApplicableActive Not Recruiting

Learning by Heart: The Effectiveness of an EF Training Program for Pre-schoolers With a Severe CHD

Role: lead

NCT06935825Recruiting

Respiratory Muscles in End-stage Lung Disease: Pathophysiological Processes & Clinical Consequences

Role: collaborator

NCT07715968Not ApplicableRecruiting

The Turbine-based CO2 Insufflator Pediatric Feasibility Study

Role: lead

NCT06414200Not ApplicableRecruiting

Nutritional Care After Discharge in Children Term Born-18years Old

Role: lead

NCT07692295Not Yet Recruiting

Biomarkers for Post-treatment Control in HIV: International Study of the EU2Cure Research Consortium (Phase I)

Role: lead

NCT07690618Phase 1Not Yet Recruiting

Thermotherapy for Head and Neck Cancer Patients

Role: lead

NCT07108244Not ApplicableEnrolling By Invitation

Use of [18F]FET PET-MRI to Improve Detection of Pituitary Adenomas in Cushing's Disease

Role: collaborator

NCT07497724Active Not Recruiting

Odevixibat Outcomes in Patients With PFIC Versus an External Control Cohort (OvEC-PFIC)

Role: collaborator

NCT05321706Phase 3Active Not Recruiting

DAPAgliflozin for Renal Protection in Heart Transplant Recipients

Role: collaborator

NCT05899114Not ApplicableCompleted

Less Is More: Optimized Pharmacotherapy With Improved coNtinuity of CarE in hospitaLized oLder peOple

Role: collaborator

NCT05276791Not ApplicableRecruiting

EMR Versus ESD for Barrett's Neoplasia

Role: collaborator

NCT07674537Not ApplicableNot Yet Recruiting

Bilirubin Thresholds in Preterm Infants on Neonatal Intensive CarE Units: The B-NICE Trial

Role: collaborator

NCT07668856Phase 3Recruiting

Cannabidiol as add-on Therapy for Children With Refractory Epilepsy (CBD-uN1que), a High-quality Individualized Approach: a Series of N-of-1 Trials

Role: collaborator

NCT06525753Recruiting

Weaning is Winning? (WeWin Study)

Role: collaborator

NCT06051188Not ApplicableTerminated

FCV vs PCV in Moderate to Severe ARDS

Role: lead

NCT06049953Recruiting

Maternal And Infant Antipsychotic Study

Role: collaborator

NCT07650396Phase 3Recruiting

The ASPIRE Trial: AchilleS tendinoPathy Treated With cortIcosteRoid injEctions

Role: lead

NCT07651748Phase 1Enrolling By Invitation

Secretin in Ex-situ Liver Perfusion

Role: lead